Amato Jussara, Miglietta Giulia, Morigi Rita, Iaccarino Nunzia, Locatelli Alessandra, Leoni Alberto, Novellino Ettore, Pagano Bruno, Capranico Giovanni, Randazzo Antonio
Department of Pharmacy, University of Naples Federico II, via D. Montesano 49, 80131 Naples, Italy.
Department of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, 40126 Bologna, Italy.
J Med Chem. 2020 Mar 26;63(6):3090-3103. doi: 10.1021/acs.jmedchem.9b01866. Epub 2020 Mar 18.
Targeting G-quadruplex structures is currently viewed as a promising anticancer strategy. Searching for potent and selective G-quadruplex binders, here we describe a small series of new monohydrazone derivatives designed as analogues of a lead which was proved to stabilize G-quadruplex structures and increase R loop levels in human cancer cells. To investigate the G-quadruplex binding properties of the new molecules, biophysical studies were performed employing both telomeric and oncogene promoter G-quadruplex-forming sequences. The obtained results allowed the identification of a highly selective G-quadruplex ligand that, when studied in human cancer cells, proved to be able to stabilize both G-quadruplexes and R loops and showed a potent cell killing activity associated with the formation of micronuclei, a clear sign of genome instability.
靶向G-四链体结构目前被视为一种有前景的抗癌策略。为了寻找强效且具选择性的G-四链体结合剂,我们在此描述了一小系列新型单腙衍生物,它们被设计为一种先导化合物的类似物,该先导化合物已被证明能稳定G-四链体结构并提高人类癌细胞中的R环水平。为了研究这些新分子的G-四链体结合特性,我们利用端粒和癌基因启动子的G-四链体形成序列进行了生物物理研究。所得结果使我们鉴定出一种高度选择性的G-四链体配体,在人类癌细胞中进行研究时,该配体被证明能够稳定G-四链体和R环,并显示出与微核形成相关的强效细胞杀伤活性,微核形成是基因组不稳定的明显迹象。